This study examines the relationship between buprenorphine dosing during pregnancy and maternal and neonatal outcomes among Medicaid-enrolled pregnant individuals with opioid use disorder (OUD). Although the study was conducted in the United States of America, many of the techniques and information provided in the document may be of interest to stakeholders due to its focus on medical implications that may transcend demographics. The results in this study emphasize the importance of focus on medication-assisted treatment to optimize maternal and neonatal health.